Illumina India Biotechnology Private Limited
Illumina India Biotechnology Private Limited is a Private Company limited by Shares company incorporated in 2018 and based in Haryana, India. It was founded by Tan Kah Ling. Illumina India Biotechnology Private Limited operates in Wholesale Trade (NIC 51100) with authorized capital of ₹13.00 Cr and paid-up capital of ₹2.60 Cr. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
Illumina - Developer of technologies for analysis of genetic variation and function. Public Company. Raised a total funding of $28M over 11 rounds from 34 investors.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Illumina India Biotechnology Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +35d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +33d | filed |
| MGT-7 | FY2023-24 | 23 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Illumina India Biotechnology Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 515610976 | ICICI Bank Ltd(Bank) | ₹9.55 Cr | 27 Jan 2022 | Open |
| 288644454 | Axis Bank Ltd(Bank) | ₹10.27 Cr | 19 Sep 2022 | Open |
| 795208092 | HDFC Bank Ltd(Bank) | ₹20.29 Cr | 12 Mar 2023 | Satisfied |
| 592866968 | Kotak Mahindra Bank Ltd(Bank) | ₹16.51 Cr | 12 Mar 2021 | Satisfied |
| 971377208 | State Bank of India(Bank) | ₹16.24 Cr | 19 Sep 2019 | Open |
Charge IDs, lenders & amounts for Illumina India Biotechnology Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹56.53 Cr | ₹3.67 Cr | ₹51.06 Cr | ₹82.08 Cr | 36 |
| FY2023-24 | ₹47.61 Cr | ₹3.46 Cr | ₹35.91 Cr | ₹72.96 Cr | 217 |
| FY2022-23 | ₹40.21 Cr | ₹4.18 Cr | ₹37.00 Cr | ₹54.96 Cr | 112 |
| FY2021-22 | ₹41.89 Cr | ₹3.10 Cr | ₹31.25 Cr | ₹62.11 Cr | 117 |
Audited financials & ratios for Illumina India Biotechnology Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹56.53 Cr | ₹47.61 Cr | ₹40.21 Cr | ₹41.89 Cr |
| Other income | ₹60.23 L | ₹84.50 L | ₹20.44 L | ₹26.16 L |
| Total income | ₹57.14 Cr | ₹48.45 Cr | ₹40.41 Cr | ₹42.15 Cr |
| Total expenses | ₹52.44 Cr | ₹44.03 Cr | ₹35.06 Cr | ₹38.17 Cr |
| Profit before tax | ₹4.77 Cr | ₹4.49 Cr | ₹5.43 Cr | ₹4.04 Cr |
| Profit / (Loss) after tax | ₹3.67 Cr | ₹3.46 Cr | ₹4.18 Cr | ₹3.10 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹51.06 Cr | ₹35.91 Cr | ₹37.00 Cr | ₹31.25 Cr |
| Borrowings | ₹15.38 Cr | ₹12.25 Cr | ₹3.80 Cr | ₹10.54 Cr |
| Current liabilities | ₹16.09 Cr | ₹11.45 Cr | ₹9.55 Cr | ₹10.21 Cr |
| Total liabilities | ₹31.02 Cr | ₹37.05 Cr | ₹17.96 Cr | ₹30.87 Cr |
| Current assets | ₹48.51 Cr | ₹34.73 Cr | ₹25.87 Cr | ₹23.50 Cr |
| Cash & equivalents | ₹18.63 Cr | ₹10.77 Cr | ₹5.13 Cr | ₹2.96 Cr |
| Total assets | ₹82.08 Cr | ₹72.96 Cr | ₹54.96 Cr | ₹62.11 Cr |
| Employees | 36 | 217 | 112 | 117 |
Audited financials & ratios for Illumina India Biotechnology Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹56.53 Cr | +18.3% | +8.8% | +12.4% |
| Profit after Tax | ₹3.67 Cr | +24.6% | +26.2% | +12.2% |
| Net Worth | ₹51.06 Cr | +1.9% | +23.6% | +12.4% |
| Employees | 36 | +6.0% | +10.1% | +14.2% |
Audited financials & ratios for Illumina India Biotechnology Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹56.53 Cr | ₹3.67 Cr | +6.49% | -10.40% | +7.18% | +4.47% | 0.30 | ₹1.57 Cr |
| FY2023-24 | ₹47.61 Cr | ₹3.46 Cr | +7.26% | +0.23% | +9.63% | +4.74% | 0.34 | ₹21.94 L |
| FY2022-23 | ₹40.21 Cr | ₹4.18 Cr | +10.39% | +26.86% | +11.29% | +7.60% | 0.10 | ₹35.90 L |
| FY2021-22 | ₹41.89 Cr | ₹3.10 Cr | +7.41% | +14.09% | +9.94% | +5.00% | 0.34 | ₹35.80 L |
Audited financials & ratios for Illumina India Biotechnology Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 3,73,79,719 | 88.70% |
| Institutional Investors | 3 | 17,62,446 | 4.18% |
| Public & Others | 36 | 30,01,265 | 7.12% |
Promoter, institutional & public holding for Illumina India Biotechnology Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
200 peersEvents & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.